Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 12/20 | 0.52 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21359154 | 0.90 | HRH3 (0.49) | HRH3HRH4NPC1HPGDRAB9A | |
| SCHEMBL7786505 | 0.83 | EPHX1 (0.46) | HRH3HRH4NPC1HPGDRAB9A | |
| SCHEMBL457463 | 0.82 | SLC6A5 (0.52) | — | |
| SCHEMBL8823889 | 0.82 | ERAP2 (0.46) | EPHX1DPP8DPP9DPP7 | |
| SCHEMBL10769955 | 0.82 | EPHX1 (0.39) | EPHX1DPP8DPP9DPP7 | |
| SCHEMBL11783967 | 0.82 | ERAP2 (0.46) | EPHX1DPP8DPP9DPP7 | |
| SCHEMBL7534565 | 0.82 | SLC6A5 (0.52) | — | |
| SCHEMBL10766995 | 0.82 | ERAP2 (0.46) | EPHX1DPP8DPP9DPP7 | |
| SCHEMBL2356099 | 0.82 | SLC6A5 (0.52) | — | |
| SCHEMBL29368166 | 0.82 | HRH3 (0.56) | HRH3HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021133839-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2021-07-01 | — | — | WO | disclosed |